Rituximab in Adult Minimal Change Disease and Focal Segmental Glomerulosclerosis

Publisher： Karger

E-ISSN： 1660-2110|128|3-4|277-282

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.128, Iss.3-4, 2015-0, pp. : 277-282

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Focal Segmental Glomerulosclerosis – Does Treatment Work?

By  

Nephron Clin Pract, Vol. 104, Iss. 2, 2006-06 ,pp. : c83-c84

Karger

Access to resources Recommend Favorite

Collapsing Focal Segmental Glomerulosclerosis in a Young Child

By  

Nephron Clin Pract, Vol. 121, Iss. 1-2, 2012-10 ,pp. : c83-c90

Karger

Access to resources Recommend Favorite

Molecular Analysis of NPHS2 and ACTN4 Genes in a Series of 33 Italian Patients Affected by Adult-Onset Nonfamilial Focal Segmental Glomerulosclerosis

By  

Nephron Clin Pract, Vol. 99, Iss. 2, 2004-12 ,pp. : c31-c36

Karger

Access to resources Recommend Favorite

Effective treatment with rituximab for the maintenance of remission in frequently relapsing minimal change disease

By  

NEPHROLOGY, Vol. 21, Iss. 10, 2016-10 ,pp. : 893-900

John Wiley & Sons Inc

Access to resources Recommend Favorite

Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate

By Pascual J.   Torrealba J.   Myers J.   Tome S.   Samaniego M.   Musat A.   Djamali A.  

Osteoporosis International, Vol. 18, Iss. 10, 2007-10 ,pp. : 1435-1438

Springer Publishing Company

Access to resources Recommend Favorite